BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 26962850)

  • 1. Changes in Kidney Function and in the Rate of Tubular Dysfunction After Tenofovir Withdrawal or Continuation in HIV-Infected Patients.
    Casado JL; Del Rey JM; Bañón S; Santiuste C; Rodriguez M; Moreno A; Perez-Elías MJ; Liaño F; Moreno S
    J Acquir Immune Defic Syndr; 2016 Aug; 72(4):416-22. PubMed ID: 26962850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and significance of proximal renal tubular abnormalities in HIV-infected patients receiving tenofovir.
    Casado JL; Bañón S; Santiuste C; Serna J; Guzman P; Tenorio M; Liaño F; del Rey JM
    AIDS; 2016 Jan; 30(2):231-9. PubMed ID: 26684820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone mineral density decline according to renal tubular dysfunction and phosphaturia in tenofovir-exposed HIV-infected patients.
    Casado JL; Santiuste C; Vazquez M; Bañón S; Rosillo M; Gomez A; Perez-Elías MJ; Caballero C; Rey JM; Moreno S
    AIDS; 2016 Jun; 30(9):1423-31. PubMed ID: 26919733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proximal renal tubular function in HIV-infected children on tenofovir disoproxil fumarate for treatment of HIV infection at two tertiary hospitals in Harare, Zimbabwe.
    Mashingaidze-Mano R; Bwakura-Dangarembizi MF; Maponga CC; Morse GD; Monera-Penduka TG; Mtisi TJ; Mudzviti T; Mujuru HA
    PLoS One; 2020; 15(7):e0235759. PubMed ID: 32634168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early switching of tenofovir disoproxil fumarate (TDF) in HIV-infected patients with TDF-induced nephrotoxicity: a prospective study.
    Patamatamkul S; Songumpai N; Payoong P; Katavetin P; Putcharoen O
    HIV Res Clin Pract; 2022 Aug; 23(1):99-106. PubMed ID: 36065999
    [No Abstract]   [Full Text] [Related]  

  • 6. Proximal renal tubular dysfunction related to antiretroviral therapy among HIV-infected patients in an HIV clinic in Mexico.
    Andrade-Fuentes K; Mata-Marín JA; López-De León JI; Manjarrez-Téllez B; Ramírez JL; Gaytan-Martínez J
    AIDS Patient Care STDS; 2015 Apr; 29(4):181-5. PubMed ID: 25101526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Switching to abacavir versus use of a nucleoside-sparing dual regimen for HIV-infected patients with tenofovir-associated renal toxicity.
    Casado JL; Santiuste C; Vivancos MJ; Monsalvo M; Moreno A; Perez-Elías MJ; Del Rey JM; Moreno S
    HIV Med; 2018 Jun; ():. PubMed ID: 29932293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is Abnormal Urine Protein/Osmolality Ratio Associated with Abnormal Renal Function in Patients Receiving Tenofovir Disoproxil Fumarate?
    Marcelin JR; Berg ML; Tan EM; Amer H; Cummins NW; Rizza SA
    PLoS One; 2016; 11(2):e0149562. PubMed ID: 26872144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal function in Ethiopian HIV-positive adults on antiretroviral treatment with and without tenofovir.
    Yilma D; Abdissa A; Kæstel P; Tesfaye M; Olsen MF; Girma T; Ritz C; Friis H; Andersen ÅB; Kirk O
    BMC Infect Dis; 2020 Aug; 20(1):582. PubMed ID: 32762646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-Term Follow-Up of Proteinuria and Estimated Glomerular Filtration Rate in HIV-Infected Patients with Tubular Proteinuria.
    Peyriere H; Cournil A; Casanova ML; Badiou S; Cristol JP; Reynes J
    PLoS One; 2015; 10(11):e0142491. PubMed ID: 26571117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary β2 microglobulin can predict tenofovir disoproxil fumarate-related renal dysfunction in HIV-1-infected patients who initiate tenofovir disoproxil fumarate-containing antiretroviral therapy.
    Nishijima T; Kurosawa T; Tanaka N; Kawasaki Y; Kikuchi Y; Oka S; Gatanaga H
    AIDS; 2016 Jun; 30(10):1563-71. PubMed ID: 26919734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kidney dysfunction associated with tenofovir exposure in human immunodeficiency virus-1-infected Taiwanese patients.
    Huang YS; Chan CK; Tsai MS; Lee KY; Lin SW; Chang SY; Hung CC; Chang SC
    J Microbiol Immunol Infect; 2017 Oct; 50(5):595-603. PubMed ID: 26514942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Tenofovor Diproxil Fumarate on Renal Function and Urinalysis Abnormalities in HIV-Infected Cameroonian Adults.
    Fritzsche C; Rudolph J; Huenten-Kirsch B; Hemmer CJ; Tekoh R; Kuwoh PB; Glass A; Reisinger EC
    Am J Trop Med Hyg; 2017 Nov; 97(5):1445-1450. PubMed ID: 29140230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety of Tenofovir Alafenamide in People With HIV Who Experienced Proximal Renal Tubulopathy on Tenofovir Disoproxil Fumarate.
    Campbell L; Barbini B; Burling K; Cromarty B; Hamzah L; Johnson M; Jones R; Samarawickrama A; Williams D; Winston A; Post FA;
    J Acquir Immune Defic Syndr; 2021 Oct; 88(2):214-219. PubMed ID: 34506361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal Dysfunction during Tenofovir Use in a Regional Cohort of HIV-Infected Individuals in the Asia-Pacific.
    Tanuma J; Jiamsakul A; Makane A; Avihingsanon A; Ng OT; Kiertiburanakul S; Chaiwarith R; Kumarasamy N; Nguyen KV; Pham TT; Lee MP; Ditangco R; Merati TP; Choi JY; Wong WW; Kamarulzaman A; Yunihastuti E; Sim BL; Ratanasuwan W; Kantipong P; Zhang F; Mustafa M; Saphonn V; Pujari S; Sohn AH;
    PLoS One; 2016; 11(8):e0161562. PubMed ID: 27560968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Urinary Biomarkers of Kidney Injury with Estimated GFR Decline in HIV-Infected Individuals following Tenofovir Disoproxil Fumarate Initiation.
    Ascher SB; Scherzer R; Estrella MM; Zhang WR; Muiru AN; Jotwani V; Grunfeld C; Parikh CR; Gustafson D; Young M; Sharma A; Cohen MH; Ng DK; Palella FJ; Witt MD; Ho K; Shlipak MG
    Clin J Am Soc Nephrol; 2018 Sep; 13(9):1321-1329. PubMed ID: 30154221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progressive renal tubular dysfunction associated with long-term use of tenofovir DF.
    Kinai E; Hanabusa H
    AIDS Res Hum Retroviruses; 2009 Apr; 25(4):387-94. PubMed ID: 19361280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of Tenofovir on renal function among Ugandan adults on long-term antiretroviral therapy: a cross-sectional enrolment analysis.
    Salome T; Kasamba I; Mayanja BN; Kazooba P; Were J; Kaleebu P; Munderi P;
    AIDS Res Ther; 2016; 13(1):28. PubMed ID: 27582777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low Risk of Proximal Tubular Dysfunction Associated With Emtricitabine-Tenofovir Disoproxil Fumarate Preexposure Prophylaxis in Men and Women.
    Mugwanya K; Baeten J; Celum C; Donnell D; Nickolas T; Mugo N; Branch A; Tappero J; Kiarie J; Ronald A; Yin M; Wyatt C;
    J Infect Dis; 2016 Oct; 214(7):1050-7. PubMed ID: 27029778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absence of Decline of Kidney Function in Human Immunodeficiency Virus-Infected Patients Under Routine Clinical Management.
    Boucquemont J; Lawson-Ayayi S; Rigothier C; Bonnet F; Proust-Lima C; Neau D; Greib C; Miremont-Salamé G; Dabis F; Dupon M; Dauchy FA;
    Nephron; 2017; 136(3):211-220. PubMed ID: 28445881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.